Vanda Pharmaceuticals Inc. v. Apotex Inc. et al
| Vanda Pharmaceuticals Inc. |
| Apotex Corp. and Apotex Inc. |
| 1:2021cv00282 |
| February 24, 2021 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 1 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 21, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 20 Proposed STIPULATION and Order for Consolidation by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Filing 19 NOTICE OF SERVICE of Vanda Pharmaceuticals Inc.'s Intrinsic Evidence Supporting Claim Construction for Wave 3 Patents filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Filing 18 NOTICE OF SERVICE of Apotex Inc. and Apotex Corp.'s Objections and Responses to Vanda's First Interrogatory to Apotex (No. 1) Regarding U.S. Patent Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744 filed by Apotex Corp., Apotex Inc..(Francella, Thomas) |
Filing 17
ORDER: IT IS ORDERED that, on or before May 17, 2021, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 5/17/2021.) Signed by Judge Colm F. Connolly on 4/16/2021. Associated Cases: 1:21-cv-00121-CFC, 1:21-cv-00282-CFC, 1:21-cv-00283-CFC(nmf)
|
| Filing 16 NOTICE OF SERVICE of Plaintiff Vanda Pharmaceuticals Inc.'s Proposed Claims and Constructions for Wave 3 Patents filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Corporate Affiliates/Parents added per Disclosure Statement: identifying Corporate Parent Apotex Pharmaceutical Holdings, Inc. for Apotex Corp., Apotex Inc. (fms) |
| Filing 15 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings, Inc. for Apotex Corp., Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Francella, Thomas) |
| Filing 14 ANSWER to Amended Complaint, re: #10 Amended Complaint by Apotex Corp., Apotex Inc..(Francella, Thomas) |
| Filing 13 NOTICE OF SERVICE of Vanda's First Interrogatory to Apotex (No. 1) Regarding U.S. Patent Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Filing 12 NOTICE OF SERVICE of (1) Vanda's Disclosure of Asserted Claims and Contentions Regarding Infringement by Apotex of U.S. Patent Nos. 10,610,510 and 10,610,511, (2) Vanda's Disclosure of Asserted Claims and Contentions Regarding Infringement by Apotex of U.S. Patent Nos. 10,829,465 and 10,611,744, and (3) Disclosure of Accused Products and the Asserted Patents and Claims for U.S. Patent Nos. 10,610,510, 10,610,511, 10,829,465 and 10,611,744 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Filing 11 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,829,465 B2 ;10,611,744 B2 (Amended). (Fahnestock, Derek) |
| Filing 10 First AMENDED COMPLAINT for Patent Infringement against Apotex Corp., Apotex Inc.- filed by Vanda Pharmaceuticals Inc.. (Attachments: #1 Exhibits A-B)(Fahnestock, Derek) |
|
SO ORDERED, re (7 in 1:21-cv-00283-CFC, 9 in 1:21-cv-00282-CFC) MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Josephine Young, Daniel J. Klein, Jennifer Rea Deneault & Michael F. Milea filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 3/4/2021. Associated Cases: 1:21-cv-00282-CFC, 1:21-cv-00283-CFC(nmf)
|
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:21-cv-00282-CFC, 1:21-cv-00283-CFC (rjb) |
| Filing 9 MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Josephine Young, Daniel J. Klein, Jennifer Rea Deneault & Michael F. Milea - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Filing 8 SUMMONS Returned Executed by Vanda Pharmaceuticals Inc.. Apotex Corp. served on 2/25/2021, answer due 3/18/2021. (Fahnestock, Derek) |
| Filing 7 SUMMONS Returned Executed by Vanda Pharmaceuticals Inc.. Apotex Inc. served on 2/25/2021, answer due 3/18/2021. (Fahnestock, Derek) |
| Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (amf) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Blackrock for Vanda Pharmaceuticals Inc. - filed by Vanda Pharmaceuticals Inc.. (amf) |
| Filing 4 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/18/2020. Date of Expiration of Patent: 2/12/2035.Thirty Month Stay Deadline: 7/31/2021. (amf) |
| Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,829,465 B2. (amf) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (amf) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Apotex Corp., Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3544059.) - filed by Vanda Pharmaceuticals Inc. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(amf) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
